0.94 USD
▼+0.02-3.76%
盘后 0.94 -4.58%
2026-08-03
市值
$32.13M
市盈率
—
EPS
-2.21
股息率
—
52 周区间
0.69 – 5.55
成交量
150.43K
Beta
0.05
目标价
—
52W 低 0.6952W 高 5.55
价格走势
公司简介
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.